| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 06/30/2004 | EP1433480A1 Medicine containing pyrimidine derivative |
| 06/30/2004 | EP1432777A1 Fluorescent diketopyrrolopyrrole analogues |
| 06/30/2004 | EP1432734A1 Cytokine receptor |
| 06/30/2004 | EP1432721A1 Process for the preparation of rebeccamycin and analogs thereof |
| 06/30/2004 | EP1432715A2 Pyrimidine derivatives |
| 06/30/2004 | EP1432714A2 Chemical compounds |
| 06/30/2004 | EP1432713A2 Fused pyrimidine dhfr inhibitors as antibacterials |
| 06/30/2004 | EP1432707A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 06/30/2004 | EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 06/30/2004 | EP1432700A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 06/30/2004 | EP1315730B1 1-(alkyl), 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo(1,2-a)pyrimidin-5(1h)-one derivatives |
| 06/30/2004 | EP1313370B1 Fungicidal formulation |
| 06/30/2004 | CN1509289A Imidazo[1,5,-A] pyrimido[5,4-d]benzazepine derivatives as GABAA receptor medulators |
| 06/30/2004 | CN1509288A The citrate salt of 5,8,14-triazatetracyclo (10.3.1.0.2,11.0.4,9)-hexadeca-2.(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509270A Indolinons, substituted in position 6, and their preparation and use as kinase inhibitors |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509143A Microbicides asing triazolopyrimidine derivatives as protection materials |
| 06/30/2004 | CN1508137A 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor |
| 06/30/2004 | CN1155600C 2,3-diaryl-pyrazolo[1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2(cox-2) inhibitors |
| 06/30/2004 | CN1155599C Tricyclic triazolobenzazepine derivatives, process for producing same, and antiallergic agent |
| 06/30/2004 | CN1155584C Process for preparation of 1,4,7,10-tetraazacyclododecane |
| 06/30/2004 | CN1155580C Process for directly synthesizing pyrimidine, 1,3,5-triazine, phthalocyanine and polynitrile from nitrile |
| 06/30/2004 | CN1155572C Indole derivatives and its anticancer usage |
| 06/29/2004 | US6756396 Ethylene glycol esters as photoactive agents |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756388 Having piperidinyl and phenolic functionality; bone loss; breast or prostate cancer |
| 06/29/2004 | US6756376 Preventing fatty acid release |
| 06/29/2004 | US6756373 Such as 5-(2-butoxy-5-iodo-3-pyridinyl)-3-ethyl-2-(2-methoxy-ethyl)-2,6-dihydro-7h -pyrazolo(4,3-d)pyrimidin-7-one; cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors; erectile dysfunction |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756367 Useful in the treatment of any state with increased endogenous level of corticotropin releasing hormone(crf) or hpa (hypothalamic pituitary axis) is disregulated or diseases induced by crf, including inflammatory disorders, anxiety etc |
| 06/24/2004 | WO2004052889A1 Compounds as radioligands for the diagnosis of disease |
| 06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052315A2 Tyrosine kinase inhibitors |
| 06/24/2004 | WO2004052288A2 2-nh-heteroarylimidazoles with antibacterial activity |
| 06/24/2004 | WO2004052286A2 Tyrosine kinase inhibitors |
| 06/24/2004 | WO2004035576A3 Pre-organized tricyclic integrase inhibitor compounds |
| 06/24/2004 | WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122234 Growth Hormone secretagogues |
| 06/24/2004 | US20040122074 1-[5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-methyl-1H-pyrazol-3-yl]-2-piperidin-1-yl-ethanone,e.g. as antagonist or inverse agonists; nicotine partial agonist; an opioid antagonist; a dopaminergic agent; an attention deficit disorder agent |
| 06/24/2004 | US20040122063 Ethylenediamine derivatives |
| 06/24/2004 | US20040122046 NPY-5 antagonists |
| 06/24/2004 | US20040122012 such as 2,2,N,N-tetramethyl-N-(3-phenyl-[1,2,4]triazolo[3,4- alpha ]phthalazin-6-yl)-propane-1,3-diamine; for use in chemotherapy |
| 06/24/2004 | US20040122010 Treatment of neuropathy |
| 06/24/2004 | US20040122002 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 06/24/2004 | DE10257394A1 New 7-amino-6-phenyl-triazolopyrimidine derivatives are broad-spectrum fungicides useful in protection of plants or materials such as wood |
| 06/24/2004 | DE10256264A1 New trisubstituted dihydro-imidazo-pyridazinone or imidazo-pyridinone derivatives, useful as dipeptidylpeptidase-IV inhibitors for e.g. treating diabetes mellitus type I or II, arthritis or obesity |
| 06/24/2004 | CA2508147A1 2-nh-heteroarylimidazoles with antibacterial activity |
| 06/24/2004 | CA2505887A1 Pyrazole and imidazole compounds and uses thereof |
| 06/23/2004 | EP1431299A1 IMIDAZO(1,2-a)PYRIMIDINES AND FUNGICIDE COMPOSITIONS CONTAINING THE SAME |
| 06/23/2004 | EP1431286A2 Prodigiosin derivatives for treating cancer or viral diseases |
| 06/23/2004 | EP1430898A1 Receptor antagonist |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430061A1 Inclusion compound comprising cucurbituril derivatives as host molecule and pharmaceutical composition comprising the same |
| 06/23/2004 | EP1430058A1 Sodium salt of an hiv integrase inhibitor |
| 06/23/2004 | EP1430057A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives |
| 06/23/2004 | EP1430056A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 06/23/2004 | EP1430055A1 7-tert-butyl-3-(2-fluorophenyl)-6-(2h-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine for the treatment of anxiety and convulsions |
| 06/23/2004 | EP1430054A2 Purification and crystalline forms of zaleplon |
| 06/23/2004 | EP1430050A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 06/23/2004 | EP1430036A1 Novel method of preparing nitrogen macrocycles |
| 06/23/2004 | EP1430033A1 Anti-inflammatory and protein kinase inhibitor composition and method of use |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1429758A1 Photodynamic porphyrin antimicrobial agents |
| 06/23/2004 | EP1255753B1 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 06/23/2004 | EP1204475B1 Immobilized photocatalyst |
| 06/23/2004 | EP1071427B1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 06/23/2004 | EP0779889B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1154650C Triazole-[4,5-d] pyrididines compound, its preparation, use and medical composition containing the same |
| 06/23/2004 | CN1154494C Adenosine A3 receptor modulators |
| 06/22/2004 | US6753430 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
| 06/22/2004 | US6753329 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 06/17/2004 | WO2004050716A2 Preparation of metallotexaphyrins |
| 06/17/2004 | WO2004050681A2 Kinase modulators |
| 06/17/2004 | WO2004050659A1 Novel compounds as pharmaceutical agents |
| 06/17/2004 | WO2004050658A1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments |
| 06/17/2004 | WO2004050657A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050039A2 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | WO2004029204A3 Substituted pyrimidines |
| 06/17/2004 | WO2004026229A3 Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors |
| 06/17/2004 | WO2004013282A3 Bis (amino acid) molecular scaffolds |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116689 can comprise DNA, RNA, PNA, or any combination or chimera thereof |
| 06/17/2004 | US20040116473 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 06/17/2004 | US20040116457 Agents for improving excretory potency of urinary bladder |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116447 Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
| 06/17/2004 | US20040116446 Nitrogen compounds having improved solubility, bioavailability and stability, used as sedatives, anxiolytics, anticonvulsant, and/ or muscle relaxants for prophylaxis of sleep disorders |
| 06/17/2004 | US20040116442 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040116437 5HT2C Receptor agonist for treatment of disorders of central nervous system such as obsessive compulsive disorders, depression or anxiety |
| 06/17/2004 | US20040116433 Triazolo[4,3b]pyridazine to inhibit activity of serine/threonine protein kinases tor treatment of cancer with administering |